Impact of gastroesophageal reflux disease on the quality of life of Spanish patients: The relevance of the biometric factors and the severity of symptoms

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 620-629

  Ponce, Julio ^a   Beltran, Belen ^a   Ponce, Marta ^a   Zapardiel, Javier ^b   Ortiz, Vicente ^a   Vegazo, Onofre ^b   Nuevo, Javier ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Medical Department   (Spain)

Author keywords

Acidity; Esophagus; GERD; H; L; O; Q; R

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BIOMETRY; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DETERIORATION; DISEASE DURATION; DISEASE SEVERITY; DRINKING BEHAVIOR; DYSPEPSIA; EMOTION; EMOTIONAL STRESS; FEEDING BEHAVIOR; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OBESITY; PHYSICAL CAPACITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORM 36; SLEEP DISORDER; SMOKING; SMOKING HABIT; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; SPAIN; SYMPTOM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTHROPOMETRY; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OBESITY; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SLEEP DISORDERS; SMOKING; SPAIN; YOUNG ADULT;

EID: 67649666824     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328310abe9     Document Type: Article

References (39)

1. Pacini F, CalabreseC, Cipolleta L,Valva, MD, Russo A, Savarino V, Vigneri S. Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opinio. 2005; 21:495-502.
2. Madisch A, Kulich KR, Malfertheiner P, Ziegler K, Bayerdorffer E, Miehlke S, et al. Impact of reflux disease on general and disease-related quality of life: Evidence from a recent comparative methodological study in Germany. Z Gastroentero. 2003; 41:1137-1143.
3. Pique JM, Kulich KR, Vegazo O, Jimenez J, Zapardiel J, Carlsson J, Wiklund IK. Burden of Gastroesophageal reflux disease. Evidence from a recent methodological study in Spain. Gastroenterol Hepato. 2004; 27:300-306.
4. El-Dika S, Guyatt GH, Armstrong D, Deglinnocenti A, Wilkund I, Fallone CA, et al. The impact of illness in patients with moderate to severe gastro- espophageal reflux disease. BMC Gastroentero. 2005; 5:23-31.
5. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Me. 1998; 104:252-258.
6. Dimenas E. Methodological aspects of evaluation of quality if life un upper gastrointestinal diseases. Scand J Gastroenterol Supp. 1993; 199:18-21.
7. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH Berry SD, et al. Functional status and well-being if patients with chronic conditions: results from the Medical Outcomes Study. J Am Med Asso. 1989; 262: 907-913.
8. Dimenas E, Glise H, Hallerback B, Herngvist H, Svedlund J, Wiklund I. Well- being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroentero. 1995; 30:1046-1052.
9. Dimenas E, Carisson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as a part of documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroentero. 1996; 31 (Suppl 221):8-13.
10. Kaplan-Machlis B, Spiegler GE, Revicki DA. Health-related quality of life in primary care patients with gastroesophageal reflux disease. Ann Pharmaco. 1999; 33:1032-1036.
11. Eloubeidi NA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease without Barrett's esophagus. Am J Gastroentero. 2000; 95:1881-1887.
12. Shaker R, Brunton S, Elfant A, Golopol L, Ruoff G, Stanghellini V. Review article: impact of night-time reflux on lifestyle: unrecognized issues in reflux disease. Aliment Pharmacol The. 2004; 20 (Suppl 9):3-13.
13. Ponce J, Vegazo O, Beltran B, Jimenez J, Zapardiel J, Calle D, Pique JM. Prevalence and factors associated with gastro-oesophageal reflux disease (GORD) in Spain. Aliment Pharmacol The. 2006; 23:175-183.
14. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Car. 1992; 30:473-483.
15. Alonso J, Prieto L, Anto JM. The Spanish version of the SF-36 Health Survey (The SF-36 questionnaire): an instrument for measuring clinical results. Med Clin (Bare. 1995; 104:771-776.
16. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Supp. 1998; 583:41-49.
17. Kulich KR, Pique JM, Vegazo O, Jimenez J, Zapardiel J, Carisson J, Wiklund I. Psychometric validation of translation to Spanish of the gastrointestinal symptoms rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) in patients with gastroesophageal reflux. Rev Clin Es. 2005; 205:588-594.
18. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient- reported outcomes: the example of health-related quality of life: A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journa. 2002; 36:209-238.
19. Alonso J, Regidor E, Barrio G, Prieto L, Rodriguez C, De la Fuente L Population reference values of the Spanish version of the Health Questionnaire SF-36. Med Clin (Bare. 1998; 111:410-416.
20. Ware JE Jr, Kosinski M. SF-36 physical and mental health summary scales: a manual for users of version 1. Second edition. Lincolnn Rl: Qualimetric Inc; 2001.
21. Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S, Wiklund I, et al. Measuring change in quality of life in response to Helicobacter pylor., eradication in peptic ulcer disease: the QOLRD. Dig Dis Sc. 2001; 46:571-580.
22. Wahlqvist P, Carisson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastroesophageal reflux disease (WPAI-GERD): results form a cross-sectional study. Value in Healt. 2002; 5:106-113.
23. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroentero. 2001; 96:1998-2004.
24. World Health Organization Report: Obes/fy.preventing and managing the global epidemic. Geneva: WHO Technical Report Series No. 894; 2000.
25. The SAS System for Windows. Copyright © 1999-2001 by SAS Institute Inc., Cary, NC, USA. SAS Proprietary Software Release 8.2 (TS2MO).
26. Hailing K, Langstrom G, Wiklund I. Handling missing data in quality of life questionnaires: experience from clinical trials. Proceedings for the 6th Annual Conference of the International Society for Quality of Life Research, 1999; Barcelona, Spain.
27. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kharilas PJ, et al. An evidence-based appraisal of reflux disease management. The Genval workshop report. Guf 1999; 44 (Suppl 2):S1-S16.
28. National Heartburn Alliance. Survey 2000 results: a community perspective. 2000. Available at: http://www.heartburnalliance.org/survey2000. pdf.
29. American Gastrointestinal Association. Understanding Heartburn in America. 2000. Available at: http://www.gastro.org/rnedia/newsRelease00/ studyNightime.html.
30. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Me. 2001; 161:45-52.
31. Shaker R, Castell DO, Schoenfeld P, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroentero. 2003; 98:1487-1493.
32. Isolauri J, Latppala P. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population. Ann Me. 1995; 27:67-70.
33. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. W Z Med. 2000; 113:178-181.
34. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton U III. Risks factors associated with symptoms of gastroesophageal reflux. Am J Me. 1999; 106:642-649.
35. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the etiology of gastro-oesophageal reflux. Gu. 2004; 53:1730-1735.
36. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Supp. 1999; 231:20-28.
37. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR III, Rodriguez- Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol The. 2004; 19:95-105.
38. Murray L, Johnston B, Lane A, Harvey I, Donovan J, Nair P, Harvey R. Relationship between body mass and gastro-esophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemio. 2003; 32: 645-650.
39. Corley DA, Kubo A. Body mass index and Gastroesophageal reflux disease: 'a systematic review and meta-analysis'. Am J Gastroentero. 2006; 101: 2619-2628.